Francis Medical Highlights Engagement Around Major Urology Congress

According to a recent LinkedIn post from Francis Medical, the company is present around the European Association of Urology Congress 2026 in London, highlighting the EAU Prostate Cancer Run and participation by team member James Wright. The post also reiterates that the company’s urology-related technology is FDA cleared and directs viewers to its website for safety information.

The post suggests that Francis Medical is engaging with the international urology community at a major specialty congress, which may help deepen relationships with clinicians and key opinion leaders. For investors, visibility at EAU and emphasis on FDA-cleared status could support long-term adoption prospects and reinforce the company’s positioning within the prostate cancer treatment ecosystem.